4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-26-031925
Chief Executive Officer gave up 4,344 shares (to pay taxes)
- Chief Executive Officer acquired 9,801 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robinson Chandler Chief Executive Officer | 2026-09-30 | Option exercise | +9,801 | 109,068 | D | ||
| Robinson Chandler Chief Executive Officer | 2026-09-30 | Shares withheld for taxes | −4,344 | $79.67 | $346,086 | 104,724 | D |
| Derivatives | |||||||
| Robinson Chandler Chief Executive Officer | 2026-09-30 | Option exercise · Restricted Stock Unit | −9,801 | 83,602 | D | ||
Loading xslF345X06/rdgdoc.xml…